← THE WIRE
1D EOD · SEP 25 CLOSE
● Earnings · Medical DevicesGlobeNewswire · AI-written from GlobeNewswire reporting · checked automatically, not by a personWho answers for this

CooperCompanies Announces Third Quarter 2026 Results

CooperCompanies reported fiscal third-quarter 2026 results for the period ended July 31, 2026, without disclosing financial figures in the announcement excerpt. The setup remains evidence-light until the full quarter’s revenue, margins and outlook can establish whether the company’s growth profile is improving or slowing.

Keep this report. See new evidence in Following.
The storyAI-written · 1 min read

CooperCompanies announced results for its fiscal third quarter ended July 31, 2026. The company is a global medical-device maker.

The latest company-level figures are annual results for the fiscal year ended October 31, 2025: revenue was $4.1B, up 5.1% year over year, with a 65.5% gross margin, a 9.2% net margin and $1.87 in diluted EPS. Those figures provide a baseline for comparison.

For CooperCompanies, the key transmission mechanism is operating performance in its medical-device businesses: quarterly sales growth would flow into gross profit and earnings, while margin or guidance changes would affect the valuation assigned to the existing growth profile.

The balance between a positive earnings surprise and a disappointing print depends on the detailed quarterly release or filing, including revenue, EPS, segment performance, margins and forward guidance.

The read · Sep 9

The results announcement puts COO’s risk in a holding pattern: its $4.1B annual revenue base and 5.1% growth are supportive, but the quarter’s undisclosed figures leave the earnings read unresolved.

The trade read cannot move beyond neutral because the announcement excerpt confirms the reporting period but supplies no quarterly revenue, earnings, margin or guidance figures. COO’s older fiscal-2025 baseline—$4.1B of revenue, 5.1% year-over-year growth, a 65.5% gross margin and a 9.2% net margin—supports a credible operating franchise, but it does not show whether the July quarter improved or weakened.

What could change this view

A full release showing a material earnings miss, margin compression or weaker guidance would invalidate the supportive baseline; stronger-than-expected figures would invalidate the neutral stance.

CoverageSource: GlobeNewswire · Published here WED, SEP 9 · 4:17 PM ET · the only report in this recordHow this is decided →

Named in the readCOO 0.0%1D EOD · SEP 25
The chart · COOTradingView · third-party feed, not the Wire’s licensed closes
🔒 Click to interact · scroll moves the page
Story timeline0 later reports

Earlier context and later coverage are dated relative to this report. Automatically linked reports may cover a broader event.

You are reading this report

No later reports linked yet.

Follow this story to find new evidence in your Following desk.

Since this story · named here, equal weight · 1D EOD+2.2%
SEP 10 · first close after publicationSEP 25

Price context does not establish that the story caused the move.

▲ The case it holds

The bull case rests on COO extending its established fiscal-2025 profile of $4.1B revenue, 5.1% year-over-year growth and a 65.5% gross margin, but the announcement excerpt does not yet show that it did.

▼ The case it breaks

The opposing case remains ungrounded until the detailed results are disclosed.

Receipts
Research, not advice.

Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →

SharePost on X
READER EVIDENCEOpens with the recordFollow the story to be told when it moves.